Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
Biancone L, Gionchetti P, Blanco Gdel V, Orlando A, Annese V, Papi C, Sostegni R, D'Incà R, Petruzziello C, Casa A, Sica G, Calabrese E, Campieri M, Pallone F. Biancone L, et al. Among authors: casa a. Dig Liver Dis. 2007 Apr;39(4):329-37. doi: 10.1016/j.dld.2007.01.012. Epub 2007 Mar 7. Dig Liver Dis. 2007. PMID: 17347061 Clinical Trial.
Familial occurrence of inflammatory bowel disease in celiac disease.
Cottone M, Marrone C, Casà A, Oliva L, Orlando A, Calabrese E, Martorana G, Pagliaro L. Cottone M, et al. Among authors: casa a. Inflamm Bowel Dis. 2003 Sep;9(5):321-3. doi: 10.1097/00054725-200309000-00006. Inflamm Bowel Dis. 2003. PMID: 14555916
Severe acute colitis associated with CMV: a prevalence study.
Criscuoli V, Casà A, Orlando A, Pecoraro G, Oliva L, Traina M, Rizzo A, Cottone M. Criscuoli V, et al. Among authors: casa a. Dig Liver Dis. 2004 Dec;36(12):818-20. doi: 10.1016/j.dld.2004.05.013. Dig Liver Dis. 2004. PMID: 15646428
Letter: mesalazine-a safe drug with rare serious adverse events.
Scrivo B, Renna S, Casà A, Monachino N, Macaluso FS, Orlando A. Scrivo B, et al. Among authors: casa a. Aliment Pharmacol Ther. 2020 Jun;51(11):1210-1211. doi: 10.1111/apt.15691. Aliment Pharmacol Ther. 2020. PMID: 32424923 No abstract available.
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease.
Macaluso FS, Cappello M, Crispino F, Grova M, Privitera AC, Piccillo G, Magnano A, Ferracane C, Belluardo N, Giangreco E, Fries W, Viola A, Di Mitri R, Mocciaro F, Camilleri S, Garufi S, Renna S, Casà A, Maida M, Orlando A; Sicilian Network for Inflammatory Bowel Disease (SN-IBD). Macaluso FS, et al. Among authors: casa a. Dig Liver Dis. 2022 May;54(5):629-634. doi: 10.1016/j.dld.2021.11.021. Epub 2021 Dec 16. Dig Liver Dis. 2022. PMID: 34924320
71 results